Neglected Testing for Neglected Tropical Diseases at the CDC

In September 2021, the CDC suspended operations for diagnostic testing for most assays for parasitic diseases. The suspension covered more than 20 diagnostic tests for parasitic infections, including molecular and serological methodologies, morphological identification, and antimicrobial susceptibil...

Full description

Saved in:
Bibliographic Details
Published in:The American journal of tropical medicine and hygiene 2022-06, Vol.106 (6), p.1571-1573
Main Authors: Beatty, Norman L, Forsyth, Colin J, Gilman, Robert H, Hamer, Davidson H, Henao-Martínez, Andrés F, Hochberg, Natasha, Manne-Goehler, Jen, Marcus, Rachel, Meymandi, Sheba, Reich, Michael R, Showler, Adrienne, Stigler Granados, Paula
Format: Article
Language:English
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:In September 2021, the CDC suspended operations for diagnostic testing for most assays for parasitic diseases. The suspension covered more than 20 diagnostic tests for parasitic infections, including molecular and serological methodologies, morphological identification, and antimicrobial susceptibility testing. As of Apr 7, 2022, only three of these services have resumed (serologic testing for Chagas disease, morphologic identification of parasites, and morphologic identification of malaria parasites). The CDC has not provided dates for resuming other tests.
ISSN:0002-9637
1476-1645
DOI:10.4269/ajtmh.22-0222